Journal Article (1762)
1701.
Journal Article
98, pp. 11142 - 11147 (2001)
A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: Implications for the design of agonists and antagonists. Proceedings of the National Academy of Sciences 1702.
Journal Article
10, pp. 2050 - 2062 (2001)
Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1. Protein Science 1703.
Journal Article
10, pp. 2050 - 2062 (2001)
Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1. Protein Science 1704.
Journal Article
10, pp. 2050 - 2062 (2001)
Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1. Protein Science 1705.
Journal Article
22 (1), pp. 47 - 56 (2001)
Pharmacological characterization of recombinant rat corticotropin releasing factor binding protein using different sauvagine analogs. Peptides 1706.
Journal Article
20 (11), pp. 4120 - 4128 (2000)
Uncoupling of Myelin Assembly and Schwann Cell Differentiation by Transgenic Overexpression of Peripheral Myelin Protein 22. The Journal of Neuroscience 1707.
Journal Article
20 (10), pp. 3714 - 3724 (2000)
Neuronal Basic Helix-Loop-Helix Proteins (NEX and BETA2/Neuro D) Regulate Terminal Granule Cell Differentiation in the Hippocampus. The Journal of Neuroscience 1708.
Journal Article
6, pp. 56 - 61 (2000)
Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nature Medicine 1709.
Journal Article
883 (1), pp. 234 - 246 (1999)
Distinct Phenotypes Associated with Increasing Dosage of the PLP Gene: Implications for CMT1A Due toPMP22Gene Duplication. Annals of the New York Academy of Sciences 1710.
Journal Article
883 (1), pp. 254 - 261 (1999)
The “CMT Rat”: Peripheral Neuropathy and Dysmyelination Caused by Transgenic Overexpression ofPMP22. Annals of the New York Academy of Sciences 1711.
Journal Article
883 (1), pp. 247 - 253 (1999)
Transgenic Mouse Models of CMT1A and HNPP. Annals of the New York Academy of Sciences 1712.
Journal Article
14 (1), pp. 41 - 51 (1999)
Myelination in the Absence of Galactolipids and Proteolipid Proteins. Molecular and Cellular Neuroscience 1713.
Journal Article
97, pp. 595 - 606 (1999)
Transgenic Lewis rats overexpressing the proteolipid protein gene: myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathologica 1714.
Journal Article
6 (11), pp. 1035 - 1053 (1999)
Actions of CRF and its analogs. Current medicinal chemistry 1715.
Journal Article
143 (3), pp. 767 - 75 (1998)
Cell cycle-related changes in the conducting properties of r-eag K+ channels. J Cell Biol 1716.
Journal Article
9, pp. 903 - 904 (1998)
Evidence against altered forms of MAG in the dysmyelinated mouse mutant claw paw. Mammalian Genome 1717.
Journal Article
8 (4), pp. 771 - 793 (1998)
Mouse Models of Myelin Diseases. Brain Pathology 1718.
Journal Article
52 (6), pp. 633 - 640 (1998)
Molecular cloning and transfection studies of M6b-2, a novel splice variant of a member of the PLP-DM20/M6 gene family. Journal of Neuroscience Research 1719.
Journal Article
280 (5369), pp. 1610 - 1613 (1998)
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin. Science 1720.
Journal Article
41 (5), pp. 344 - 358 (1998)
Current concepts of PLP and its role in the nervous system. Microscopy Research and Technique